Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Natural Products

BASF invests in biosurfactants

by Craig Bettenhausen
March 12, 2021 | A version of this story appeared in Volume 99, Issue 9

 

BASF is deepening its involvement in glycolipid surfactants with two deals. BASF has taken a stake in Allied Carbon Solutions, becoming the Japanese sophorolipid specialist’s largest shareholder. In 2020, BASF and Allied launched a sophorolipid ingredient in Asia called BioToLife, which the firms say offers surfactant and antimicrobial action. Separately, BASF and the English biosurfactant maker Holiferm will jointly develop other glycolipid surfactants for use in home care, personal care, and industrial formulations. Both BASF partners make their surfactants by fermentation.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.